Literature DB >> 8479544

5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex.

R M Johnson1, G T Inouye, R M Eglen, E H Wong.   

Abstract

The objective of this study was to explore the role of 5-HT3 receptors in modulating potassium (K+)-evoked release of [3H]-acetylcholine ([3H]-ACh) from superfused slices of rat entorhinal cortex previously loaded with [3H]-choline. Rat entorhinal cortices were cross-chopped into 300 microns slices, superfused with oxygenated Krebs buffer containing 2.5 mmol/l Ca2+ and stimulated with two consecutive exposures of 20 mmol/l K+ for 4 min (S1 and S2, respectively). Compounds were added 20 min before S2 stimulation and remained in the superfusion buffer for the duration of the experiment. The S2/S1 ratio was then calculated. Stimulated release of [3H]-ACh was dependent on extracellular Ca2+ and K+ concentration. In Sprague Dawley rats, 2-methyl-5-HT (10(-9)-10(-6) mol/l), in the presence of 1 mumol/l ritanserin or 1 mumol/l ondansetron, had no influence on K(+)-evoked release of [3H]-ACh. In slices prepared from Hooded Lister rats, 2 mumol/l 5-HT but not 2-Me-5-HT significantly (P < 0.05) inhibited K(+)-evoked [3H]-ACh release only 17% in the presence of 1 mumol/l ritanserin. However, 2 mumol/l 2-Me-5-HT plus 1 nmol/l ondansetron had no effect. High performance liquid chromatography coupled to electrochemical detection (HPLC-ECD) was used to monitor endogenous release of ACh in the above conditions to confirm data from the radiolabelled experiments. No significant inhibition or increase in K(+)-evoked ACh release was observed with either 5-HT3 receptor agonists or antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479544     DOI: 10.1007/bf00167441

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

Review 1.  The psychopharmacology of 5-HT3 receptors.

Authors:  B Costall; R J Naylor; M B Tyers
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

2.  5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue.

Authors:  J M Barnes; N M Barnes; B Costall; R J Naylor; M B Tyers
Journal:  Nature       Date:  1989-04-27       Impact factor: 49.962

Review 3.  5-HT receptors: subtypes and second messengers.

Authors:  D Hoyer; P Schoeffter
Journal:  J Recept Res       Date:  1991

4.  Ionic basis of inhibitory presynaptic modulation in rat cortical synaptosomes.

Authors:  G Zoltay; J R Cooper
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

5.  Evoked release of aspartate and glutamate: disparities between prelabeling and direct measurement.

Authors:  J W Ferkany; J T Coyle
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

6.  Different effects of 8-OH-DPAT, a 5-HT1A receptor agonist, on cortical acetylcholine release, electrocortigram and body temperature in guinea pigs and rats.

Authors:  A Siniscalchi; L Beani; C Bianchi
Journal:  Eur J Pharmacol       Date:  1990-01-10       Impact factor: 4.432

7.  5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release.

Authors:  G Maura; G C Andrioli; P Cavazzani; M Raiteri
Journal:  J Neurochem       Date:  1992-06       Impact factor: 5.372

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux.

Authors:  L Beani; C Bianchi; A Siniscalchi; L Sivilotti; S Tanganelli; E Veratti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

10.  Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition.

Authors:  H Herdon; J Strupish; S R Nahorski
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

View more
  10 in total

1.  Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J J Turner; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 2.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  Effect of ramosetron, a 5-HT3 receptor antagonist on the severity of seizures and memory impairment in electrical amygdala kindled rats.

Authors:  Zeynab Sayahi; Alireza Komaki; Masoud Saidi Jam; Seyed Asaad Karimi; Safoura Raoufi; Parastoo Mardani; Marzieh Naderishahab; Abdolrahman Sarihi; Javad Mirnajafi-Zadeh
Journal:  J Physiol Sci       Date:  2022-01-16       Impact factor: 2.781

4.  Serotonergic modulation of Neural activities in the entorhinal cortex.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

5.  Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.

Authors:  T J Feuerstein; O Gleichauf; G B Landwehrmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

6.  Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin.

Authors:  B Brawek; M Löffler; D J Dooley; A Weyerbrock; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-12       Impact factor: 3.000

7.  Monoamines modulate the electrically-evoked efflux of 3H-choline from slices of guinea pig nucleus basalis magnocellularis.

Authors:  A Siniscalchi; I Badini; C Bianchi; L Beani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

8.  Ondansetron improves cognitive performance in the Morris water maze spatial navigation task.

Authors:  D J Fontana; S E Daniels; C Henderson; R M Eglen; E H Wong
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

9.  The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.

Authors:  E H Wong; R Clark; E Leung; D Loury; D W Bonhaus; L Jakeman; H Parnes; R L Whiting; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.

Authors:  E Schlicker; M Kathmann; H J Exner; M Detzner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.